カテゴリ： MarketLine, マレーシア, 企業調査

Shangri-La Hotels (Malaysia) Berhad：企業の戦略・SWOT・財務情報

◆英語タイトル：Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6308
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：32
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：マレーシア
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Shangri-La Hotels (Malaysia) Berhad – Strategy, SWOT and Corporate Finance Report
Summary

Shangri-La Hotels (Malaysia) Berhad – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Shangri-La Hotels (Malaysia) Berhad (Shangri-La), a subsidiary of Shangri-La Asia Ltd., is a diversified holding company, with major operations in hotels and beach resorts. The company owns and manages hotels and resorts in Kuala Lumpur, Penang, and Sabah regions of Malaysia. It also operates a golf course and clubhouse, commercial laundry and specializes in property management and investment. Its hotels and resorts offer services such as, restaurants, spa, health club, swimming pool, kids club, water sports, press reader, game zone, dining options and other recreational facilities. Shangri-La hotels are facilitated with Concierge service, internet facility and mini bar. Shangri-La is headquartered in Kuala Lumpur, Malaysia.

Scope

- Detailed information on Shangri-La Hotels (Malaysia) Berhad required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Shangri-La Hotels (Malaysia) Berhad in the form of a SWOT analysis
- An in-depth view of the business model of Shangri-La Hotels (Malaysia) Berhad including a breakdown and examination of key business segments
- Intelligence on Shangri-La Hotels (Malaysia) Berhad’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Shangri-La Hotels (Malaysia) Berhad, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Shangri-La Hotels (Malaysia) Berhad and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Shangri-La Hotels (Malaysia) Berhad as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Shangri-La Hotels (Malaysia) Berhad’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Shangri-La Hotels (Malaysia) Berhad: Company Overview 6
Shangri-La Hotels (Malaysia) Berhad: Overview and Key Facts 6
Shangri-La Hotels (Malaysia) Berhad: Overview 6
Shangri-La Hotels (Malaysia) Berhad: Key Facts 6
Shangri-La Hotels (Malaysia) Berhad: Key Employees 8
Shangri-La Hotels (Malaysia) Berhad: Key Employee Biographies 9
Shangri-La Hotels (Malaysia) Berhad: Major Products and Services 10
Shangri-La Hotels (Malaysia) Berhad: Company History 11
Shangri-La Hotels (Malaysia) Berhad: Management Statement 14
Shangri-La Hotels (Malaysia) Berhad: Locations and Subsidiaries 16
Shangri-La Hotels (Malaysia) Berhad: Key Competitors 18
Shangri-La Hotels (Malaysia) Berhad: Company Analysis 19
Shangri-La Hotels (Malaysia) Berhad: Business Description 19
Shangri-La Hotels (Malaysia) Berhad: SWOT Analysis 21
Shangri-La Hotels (Malaysia) Berhad: SWOT Overview 21
Shangri-La Hotels (Malaysia) Berhad: Strengths 21
Shangri-La Hotels (Malaysia) Berhad: Weaknesses 22
Shangri-La Hotels (Malaysia) Berhad: Opportunities 22
Shangri-La Hotels (Malaysia) Berhad: Threats 23
Shangri-La Hotels (Malaysia) Berhad: Recent Developments 24
Shangri-La Hotels (Malaysia) Berhad: News and Events Summary 24
Shangri-La Hotels (Malaysia) Berhad: Business Expansion 26
Shangri-La Hotels (Malaysia) Berhad: Contracts 28
Shangri-La Hotels (Malaysia) Berhad: Corporate Governance 28
Shangri-La Hotels (Malaysia) Berhad: Research & Development 28
Shangri-La Hotels (Malaysia) Berhad: Strategy and Operations 29
Appendix 30
Contact Us 30
Methodology 30
About MarketLine 31

List of Tables
Table 1: Shangri-La Hotels (Malaysia) Berhad: Key Facts
Table 2: Shangri-La Hotels (Malaysia) Berhad: Key Employees
Table 3: Shangri-La Hotels (Malaysia) Berhad: Company History
Table 4: Shangri-La Hotels (Malaysia) Berhad: Locations and Subsidiaries
Table 5: Shangri-La Hotels (Malaysia) Berhad: Key Competitors
Table 6: Shangri-La Hotels (Malaysia) Berhad: News and Events Summary
Table 7: Shangri-La Hotels (Malaysia) Berhad: Business Expansion
Table 8: Shangri-La Hotels (Malaysia) Berhad: Contracts
Table 9: Shangri-La Hotels (Malaysia) Berhad: Corporate Governance
Table 10: Shangri-La Hotels (Malaysia) Berhad: Research & Development
Table 11: Shangri-La Hotels (Malaysia) Berhad: Strategy and Operations



★海外企業調査レポート[Shangri-La Hotels (Malaysia) Berhad：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Nurix Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Nurix Inc (Nurix) formerly Kura Therapeutics Inc, is a drug development company that discovers and develops drugs which work by modulating the protein regulation machinery of the cell. The company developed a drug discovery platform based on understanding of the ubiquitin proteasome system ( …
  • Duke Energy Corporation (DUK)-石油・ガス分野：企業M&A・提携分析
    Summary Duke Energy Corporation (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also p …
  • Oncopeptides AB (ONCO)：製薬・医療：M&Aディール及び事業提携情報
    Summary Oncopeptides AB (Oncopeptides) is a clinical development pharmaceutical company that offers development of oncology therapies to treat multiple myeloma. The company’s lead product candidate Ygalo (melflufen) is a peptidase potentiated cytotoxic drug and a potent anti-angiogenetic compound, a …
  • InterDigital, Inc. (IDCC)：企業の財務・戦略的SWOT分析
    InterDigital, Inc. (IDCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Janssen Pharmaceuticals, Inc.：企業のM&A・事業提携・投資動向
    Janssen Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Janssen Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • MedDay SA：製薬・医療：M&Aディール及び事業提携情報
    Summary MedDay SA (MedDay) is a biotechnology company that develops drugs for nervous system disorders. The company provides clinical and pharmaceutical development in the field of rare inborn errors of metabolism to treat elucidation of metabolism pathways in the brain. Its pipeline products compri …
  • Hoya Corp (7741)：医療機器：M&Aディール及び事業提携情報
    Summary Hoya Corp (Hoya) is a global med-tech company that manufactures and sells precision devices and instruments built on its advanced optics technologies. Principal products include eyeglass and contact lenses, medical endoscopes, laparoscopic surgical instruments, intraocular lenses, orthopedic …
  • Cyclacel Pharmaceuticals Inc (CYCC)：企業の財務・戦略的SWOT分析
    Cyclacel Pharmaceuticals Inc (CYCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Trendlines Group Ltd (42T)：製薬・医療：M&Aディール及び事業提携情報
    Summary The Trendlines Group Ltd (Trendlines) is a commercialization company that invents, discovers, invests, and incubates medical and agricultural technologies. The company offers business incubation, partner and channel development, market strategies, business plans, research and development and …
  • Japan Pulp and Paper Company Limited：企業の戦略・SWOT・財務分析
    Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • POET Technologies Inc (PTK)：企業の財務・戦略的SWOT分析
    Summary POET Technologies Inc (POET), a subsidiary of Pinetree Capital Ltd, is a technology company that develops integrated circuit platforms. The company offers products such as narrow linewidth laser, broadband light sources, data communications products and active and passive components, among o …
  • Broadcom Inc (AVGO)：企業の財務・戦略的SWOT分析
    Broadcom Inc (AVGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • DiaMedica Therapeutics Inc (DMA)：企業の財務・戦略的SWOT分析
    Summary DiaMedica Therapeutics Inc (DiaMedica), formerly DiaMedica Inc is a clinical-stage biopharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 a …
  • Amcor Limited：企業の戦略・SWOT・財務分析
    Amcor Limited - Strategy, SWOT and Corporate Finance Report Summary Amcor Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • UNIQA Romania：企業の戦略・SWOT・財務情報
    UNIQA Romania - Strategy, SWOT and Corporate Finance Report Summary UNIQA Romania - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Beautiful Brands International, LLC：企業の戦略・SWOT・財務分析
    Beautiful Brands International, LLC - Strategy, SWOT and Corporate Finance Report Summary Beautiful Brands International, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • JSP Corp (7942)：企業の財務・戦略的SWOT分析
    JSP Corp (7942) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Hubbell Incorporated：企業の戦略・SWOT・財務情報
    Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report Summary Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PT Rekayasa Industri：企業の戦略的SWOT分析
    PT Rekayasa Industri - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • The US Oncology Network：企業の戦略的SWOT分析
    The US Oncology Network - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆